Urgente: Eurostars: Mejora y escalado a producción GMP de un nuevo balón gástrico para el tratamiento de la obesidad
Referencia : RDRNL20231215006
Caduca : 2024-02-14 00:00:00
A Dutch medtech start-up is looking for partners for a Eurostars application: i. to improve a new hydrogel gastric balloon to treat obesities and ii. to automate GMP manufacturing. The foreseen partners companies should be active in the areas of 3D-printing of small objects preferably hydrogels and/or the automation of GMP production process.
The company is planning to submit a proposal for the 6th call of the Eurostars-3 program, deadline is 14 March 2024. A research cooperation is foreseen.
A Dutch medtech start-up is specialized in de development of innovative biomedical solutions for treatment of obesity and recently developed a food-based, self-inflating and digestible gastric balloon, which you take as a pill under guidance of a professional. Obesity is one of the greatest public health challenges of the 21st century. Gastric bypass and other gastric surgeries, which are the most successful treatment options, shrink stomach volume with surgical modification. In a similar manner gastric space filling with gastric balloons shrinks stomach volume. It is anticipated that further clinical studies will demonstrate that the balloon after expanding in the acid environment of the stomach provides benefits similar to the results seen with bariatric surgery or existing gastric balloons, but without the need for trained surgeons and other advanced medical knowledge and facilities. For a Eurostars proposal the company is looking for R&D-partners: - Partners who can help to automate the manufacturing process. Experience with production lines for medical devices, 3D printing (mm scale), encapsulation, and GMP processes are a pre. - Furthermore, partners with knowledge of and/or an interest in hydrogels used in acid environments, working on an application that is not competitive with the gastric balloon. The company is planning to submit a proposal for the 6th Eurostars call, deadline is 14 March 2024. A research cooperation is foreseen. Advantages and innovation The therapy is a simple concept that will provide the benefit of a pharmaceutical dosage form (a “pill”) to treat individuals who suffer from overweight and obesity. In the “pill” a small balloon is folded which will expand in the acid environment of the stomach and will remain there for 1-2 weeks after which it will disintegrate and be digested in the intestines. The scalability extends to both the ingestion of the device and to the safe biological elimination of the expired device and is continuously renewable with additional “pills”. One or multiple balloons will be resident at any one time and the number of balloons can be adjusted to provide the most efficacious space filling for each patient. The device is constructed of food and food grade materials. Technical Specification or Expertise Sought The foreseen partners companies should be active in the following areas: - 3D-printing of small objects preferably super absorbent natural or synthetic polymers (e.g. hydrogels) and/or - the automation of GMP production process. Framework program Eureka Call title and identifier 6th call of the Eurostars-3 program Submission and evaluation scheme to be decided Anticipated project budget Coordinator required No Deadline for EoI 14/02/2024 Deadline of the call 14/02/2024 Project duration in weeks 100 Web link to the call Project title and acronym to be decided
Si estás interesado en recibir más información ponte en contacto con nosotros aquí
En esta página se encuentra una selección de oportunidades de colaboración tecnológica que se han extraído de la base de datos global de la Enterprise Europe Network que puede consultar en la web del consorcio EEN-GalacteaPlus , del cual FICYT es entidad coordinadora. También se incluye una selección de brokerage events y misiones, así como las convocatorias de programas europeos que se consideran más importantes para las empresas del Principado de Asturias.